Characterization of NS5A and NS5B Resistance-Associated Substitutions from Genotype 1 Hepatitis C Virus Infected Patients in a Portuguese Cohort

Brandão, Ruben, Marcelino, Rute, Maria de Fátima Goncalves, Isabel Diogo, A P Carvalho, Joaquim Cabanas, Inês Costa, Pedro Brogueira, F Ventura, Ana Cláudia Miranda , Kamal Mansinho, P Gomes

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

This study is focused on the prevalent NS5 coding region resistance-associated substitutions (RASs) in DAA-naive genotype (GT)1 HCV-infected patients and their potential impact on success rates. Plasma RNA from 81 GT1 HCV-infected patients was extracted prior to an in-house nested RT-PCR of the NS5 coding region, which is followed by Sanger population sequencing. NS5A RASs were present in 28.4% (23/81) of all GT1-infected patients with 9.9% (8/81) having the Y93C/H mutation. NS5B RASs showed a prevalence of 14.8% (12/81) and were only detected in GT1b. Overall 38.3% (31/81) of all GT1 HCV-infected patients presented baseline RASs. The obtained data supports the usefulness of resistance testing prior to treatment since a statistically significant association was found between treatment failure and the baseline presence of specific NS5 RASs known as Y93C/H (p = 0.04).
Original languageEnglish
Article number223
Number of pages14
JournalVIRUSES-BASEL
VolumeVol. 10
Issue numbern.º 5
DOIs
Publication statusPublished - 26 Apr 2018

Keywords

  • Direct-acting antivirals
  • Hepatitis C virus
  • NS5A
  • NS5B
  • Resistance-associated substitutions

Fingerprint Dive into the research topics of 'Characterization of NS5A and NS5B Resistance-Associated Substitutions from Genotype 1 Hepatitis C Virus Infected Patients in a Portuguese Cohort'. Together they form a unique fingerprint.

Cite this